graduations

since 1996

Name
Title
Year
Grade
Sara Elna Valentin
Novel method to examine strong cancer driver mutations
2024
MSc
Tessa Jane Divita
Exploring Methods to Analyze and Process Spatial Proteomics Data
2024
MSc
Sofie Poder Jørgensen
Exploration of Immune Cell Type Composition and How It Relates to Biological Age
2024
MSc
Paula Rodrigo Martín
Investigating regulatory motif perturbation during SARS-CoV-2 infection in a single-cell setup
2024
MSc
Naja Lange
Explore the impact of immune health on cancer outcome
2024
MSc
Farhad Zamani
miDGD: Prediction of miRNA activity levels based on gene expression data using Deep Generative Decoder model
2024
MSc
Malene Blond
Investigating PARP Inhibitor Resistance Mechanisms in Prostate Cancer Through Genome-Wide CRISPR-Cas9 Screening
2024
PhD
Namarta Tolani Wadhwani
Identification of Long Non-coding RNAs Associated with Prostate Cancer Aggressiveness
2024
MSc
Jesper Nors
Colorectal Cancer Recurrence: Algorithmic identification using national administrative data and estimation of incidence during and after postoperative surveillance in Denmark
2024
PhD
Sia Viborg Lindskrog
Molecular Subtyping and Circulating Tumor DNA Analysis in Bladder Cancer - Towards more personalized patient management
2024
PhD
Martin Rasmussen
Molecular exploration of the tumor immune microenvironment and microbiome in prostate cancer - Implications for individualized patient care
2024
PhD
Christian Bjødstrup Rygaard
Using the GLIPH2 algorithm to analyze TCR specificity in cancer patients
2023
MSc
Frederik Maarup Prip
Integrative multi-omics analysis of early stage bladder cancer to identify patients with a high risk of progression
2023
PhD
Simone Weiss
Molecular drivers of aggressiveness in prostate cancer - Paving the way for identification of novel prognostic and predictive biomarkers
2023
PhD
Judit Kisistók
Exploring the biology and clinical utility of circulating tumor DNA
2023
PhD
Amanda Frydendahl Johansen
Blood-based detection of disease in patients with colorectal cancer
2023
PhD
Emma Bollmann Hansen
Investigation of molecular biomarkers for improved and more personalized management of prostate cancer
2023
PhD
Malene Krabbe Østergaard
Circulating Tumor DNA as a Biomarker for Recurrence Risk and Residual Disease Detection in Rectal Cancer Patients Receiving Neoadjuvant Therapy
2023
MSc
Julie Rasmussen
Exploring the urinary- and tumor microbiome in patients with non-muscle-invasive bladder cancer
2023
MSc
Sofie Stokkebro Schmøkel
Intra-tumor subtype heterogeneity in human bladder tumors delineated by single nucleus RNA-sequencing
2023
PhD
Cecilie Mondrup Jacobsen
Utilising multiplexing of DNA methylation ddPCR assays may improve test sensitivity
2023
MSc
Ditte Siggaard Christensen
Deciphering the evolution of metastatic cancer
2023
PhD
Marcus Pii Lunau Blanke
Investigating stromal subtypes in the tumor microenvironment of localized prostate cancer using tissue microarrays
2023
Medical Research Year Report
Salah Mohammad Mustafa
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer (CURE)
2023
Medical Research Year Report
Mads Tseganesh Sandahl
Diagnosis and risk-stratification of prostate cancer with biomarkers and MRI
2022
PhD
Trine Strandgaard
Tumor characteristics and field cancerization as prognostic and predictive biomarkers in bladder cancer
2022
PhD
Mateo Sokač
Artificial Intelligence in Medicine: Using machine learning to improve patient stratification for precision medicine
2022
PhD
Jens Brogård Stenbye
Sequence-based neural networks applied to denoising of single-cell RNAseq data
2022
MSc
Anika Gottschalk
A reference-free strategy for detecting circulating tumor DNA
2022
MSc
Carmen Oroperv
A reference-free strategy for detecting circulating tumor DNA
2022
MSc
Mette Hansen Viuff
Genotype-phenotype relations in Turner syndrome - from epidemiology to genetics
2022
PhD
Nadia Øgaard
DNA methylation markers for blood-based detection of colorectal cancer
2022
PhD
Eva Ferlev Jensby
Profiling of diagnostic and prognostic biomarkers in biopsy naïve males undergoing MRI scan due to suspicion of prostate cancer
2022
MSc
Laura Elgaard Iisager Jensen
Detection of circulating tumor DNA in hormone-sensitive prostate cancer patients using cfMeDIP-seq
2022
Msc
Asbjørn Kjær
Establishing a pipeline for analysis of T-cell receptor sequencing data and characterizing the impact of the T-cell repertoire on the clinical outcome of bladder cancer
2022
MSc
Laura Andersen
Characterizing the role of tumor growth dynamics and proliferation in ctDNA release
2022
MSc
Janne Engestoft
Identifying Copy Number Signatures by Latent Dirichlet Allocation
2022
MSc
Astrid Minna Esbensen
A method development study to understand TurnerSyndrome associated infertility: Isolation of viable ovarian cells and deciphering of the ovarian surface-marker expression profile and cell-cell communication landscape
2022
MSc
Nanna Kristiansdottir
Exploring the TCR Repertoire for Detection of Recurrence and Progression in Bladder Cancer Patients Using TCR-Seq, and Protocol Development for Single Cell Sequencing
2022
MSc
Simon Grund Sørensen
The genetic footprint of DNA damage response deficiencies in cancer
2022
PhD
Tenna Vesterman Henriksen
Circulating Tumor DNA for Residual Disease Assessment in Colorectal Cancer; Implications for Adjuvant Treatment Decisions and Recurrence Surveillance
2022
PhD
Kia Eistrup Fonfara
The Effects of Statin Treatment on Gene Expression Patterns in Prostate Cancer
2021
Medical Research Year Report
Andrea Zauli
Detection of circulating tumor DNA using structural variants
2021
MSc
Ann Taber
Prognostic and Predictive Biomarkers in Bladder Cancer
2021
PhD
Sara Kaczor Poulsen
Biomarkers of chemotherapy response in patients with advanced bladder cancer
2021
MSc
Karoline Kondrup Torstensson
Implementation of cfMeDIP-seq for investigation of methylated ctDNA in metastatic castration resistant prostate cancer
2021
MSc
Emma Bruun Johannsen
The Genetics of Klinefelter Syndrome: Isolation of Testicular Cells and Profiling of Circular RNA
2021
MSc
Randi Istrup Juul
Characterization and use of DNA positions that are recurrently mutated across cancer patients
2021
PhD
Trine Block Mattesen
Molecular subtyping for improved prognostication of colorectal cancer
2020
PhD
Søren Klingenberg
PSMA PET/CT and new tumor markers in prostate cancer
2020
Medical Research Year Report
Jakob Haldrup
Identification of molecular drivers of prostate cancer aggressiveness and drug resistance
2020
PhD
Emma K. Bollman Laursen
Circular RNAs in Prostate Cancer and Their Potential as Clinical Biomarkers
2020
Part A / MSc
Martin Rasmussen
Investigating the tumor microenvironment of localized prostate cancer
2020
MSc
Ea Marie Sørensen
Investigation of olaparib resistance mechanisms in advanced prostate cancer
2020
MSc
Mateo Sokač
Utilization of Artificial Intelligence Towards Precision Medicine: Interplay Between Chromosomal Instability and Immune System
2020
part A / MSc
Trine Strandgaard
Comprehensive Analysis of Molecular Alterations in Normal Tissue for Prediction of Disease Outcome and Treatment Response in Bladder Cancer
2020
part A /MSc
Marianne Trier Bjerre
DNA methylation biomarkers for prostate cancer. Identification and evaluation of blood-based methylation biomarkers
2020
PhD
Maibritt Nørgaard
Identification of novel biomarkers in prostate cancer to improve clinical management
2020
PhD
Sia Viborg Lindskrog
Large-scale transcriptomic characterization of early-stage bladder cancer
2019
MSc
Gustav A. Poulsgaard
Localized Mutational Processes in Cancer
2019
MSc
Sigrid Salling Árnadóttir
Intra- and inter-tumor heterogeneity of colorectal cancer
2019
PhD
Simone Weiss
Evaluation of Cabazitaxel Resistance Mechanisms in Advanced Prostate Cancer Using CRISPR-Cas9 Screening
2019
MSc
Josephine Gladov
Characterization of a Naturally Occurring Genetic Variation Affecting the Aggressiveness of Colorectal Cancer
2019
MSc
Lena Marie Skindhøj Petersen
Circulating Tumor DNA as a Molecular Marker for Residual Disease and Early Detection of Relapses; Implication for recurrence monitoring in Metastatic Colorectal Cancer Patients
2019
MSc
Sarah Østrup Jensen
Early detection of colorectal cancer using circulating tumor DNA methylation markers
2019
PhD
Trine Line Okholm
Circular RNAs in cancer and their biomarker potential
2019
PhD
Line Bager Andersen
Assessment and validation of immune biomarker candidates for prostate cancer using tissue miceoarrays
2019
Medical Research Year Report
Emil Christensen
Circulating tumor DNA as biomarkers in advanced bladder cancer
2018
PhD
Mai-Britt Ørntoft
The development of blood-based tests for colorectal cancer screening: How far are liquid biopsy biomarkers from clinical implementation
2018
PhD
Stine Hedensted
Investigating the tumor microenvironment in localized prostate cancer as a tool for improved risk stratification and individualized treatment
2018
MSc
Malene Blond
Exploring the association between DNA repair gene mutations and sensitivity to PARP inhibitors and Platinum Based Chemotherapy in prostate cancer cell lines
2018
MSc
Tenna Henriksen
Circulating Tumor DNA as a Molecular Marker for Residual Disease and Early Detection of Relapse: Implications for Adjuvant Treatment Decisions and Recurrence Monitoring
2018
MSc
Sofie Schmøkel
Protocol Development for Single Cell Sequencing in Bladder Cancer
2018
MSc
Amanda Johansen
Development of Stranded Barcode Sequencing for Ultra-Sensitive Detection of Circulating Tumor DNA in Colorectal Cancer Patients
2018
MSc
Christian Stenvang
Profiling circRNA in Spermatogenesis
2018
MSc
Simon Grund
Detection of association between structural variation and repair pathway deficiencies across 2,800 whole-genome cancer samples
2018
MSc
Iben Lyskjær
Evaluation of molecular markers of treatment response in metastatic colon cancer
2018
PhD
Thomas Rothmann Aanstad Sørensen
Detection and Validation of Circular RNAs in Prostate Cancer and Development of Genetically Edited Cell Lines for the Prostate Cancer Candidate Biomarkers DLX1 and MEIS2 using CRISPR/Cas9
2017
MSc
Agnethe Berglund
The epidemiology of females with 46,XY disorders of sex development and males with 46,XX disorders of sex development: a nationwide study
2017
PhD
Kristian K. Ambjørn Groth
Marfan syndrome: Diagnostics, epidemiology, and aortic events
2017
PhD
Mathilde Borg Houlberg Thomsen
Characterization of tumour heterogeneity and cellular subpopulations in bladder cancer
2017
PhD
Lone Vedel Schøler
Clinical implications of analyzing circulating tumor DNA in colorectal cancer patients
2017
PhD
Randi Istrup Pedersen
Characterization of genomic positions recurrently mutated across cancer genomes
2017
MSc
Malene Juul Rasmussen
Non-coding driver detection founded on a detailed description of mutation processes in cancer
2017
PhD
Morten Møbjerg Callesen
Porcine Models of Human Cancers
2017
PhD
Tobias Madsen
Robust Statistical Methods for Significance Evaluation and Applications in Cancer Driver Detection and Biomarker Discovery
2017
PhD
Tine Maj Storebjerg
Prevalence of the HOXB13 G84E mutation in Danish men treated by radical prostatectomy and correlations with prostate cancer risk and aggressiveness
2016
Medical Research Year Report
Jakob Haldrup
Development of Novel Biomarkers for Prostate Cancer by Transcriptome Sequencing and CRISPR-Cas9 Genome-Editing
2016
MSc
Christine Kassentoft
Identification and validation of DNA methylation biomarkers predicting response towards oxaliplatin based treatment of metastatic colorectal cancer patients
2016
MSc
Siri Hundtofte Strand
The biomarker potential of DNA methylation and hydroxymethylation alterations in prostate cancer
2016
PhD
Nadia Øgaard
Identification of Novel Long Non-Coding RNAs in Prostate Cancer by Capture RNA Sequencing And Evaluation of the Diagnostic Potential of four DNA Methylation Markers for Prostate Cancer in Plasma and Serum
2016
MSc
Katrine Bødker Rubach-Larsen
Small RNA Sequencing as a Method for miRNA Detection – Prognostic Biomarkers for Prostate Cancer
2016
MSc
Christian Trolle
The impact of female X-chromosome aneuploidies on the epigenome and transcriptome
2016
PhD
Mia Møller
The Molecular Variations in Prostate Cancer – an Epigenetic Study with a Transcriptomic Twist
2016
PhD
Ann Taber
Analysis of Tumor Markers Associated with Chemotherapy Response in Patients with Advanced Bladder Cancer
2016
Medical Research Year Report
Helle Kristensen
Identification of genetic and epigenetic biomarkers for prostate cancer
2015
PhD
Sigrid Salling Árnadóttir
Intra-Tumor Heterogeneity in Colorectal Cancer
2015
MSc (part A exam)
Sarah Østrup Jensen
Identification of novel blood-based biomarkers for early detection of colorectal cancer
2015
PhD
Anne Skakkebæk
Klinefelter syndrome – brain, behavior and genetic aspects
2015
PhD
Martin Mørck Mortensen
The molecular signature of clinically localized prostate cancer
2015
PhD

MOMA
Department of
Molecular Medicine

Aarhus University Hospital

Brendstrupgårdsvej 21A
8200 Aarhus N, Denmark
‍

Contact

Laboratory:

+45 784 55330

Secretary:

+45 784 55310

moma@rm.dk

Molecular Medicine
Bladder CancerColorectal CancerProstate CancerRenal cancerGenetic Endocrinology
Bioinformatics
Computational Genomics & TranscriptomicsCancer EvolutionComputational Genomics
All
CollaborationsGraduationsPublications
Diagnostics
LaboratoryClinical BioinformaticsClinical DiagnosticsOPRA Medical Doctors
Services
NGS Core CenterCell-free Tumor DNA analysesConnectCellXRBGB
Software
Software
Danish National Genome Center
NGC
About MOMA
FrontpageHistoryStaffSocial lifeStudy environmentJobsContact
MOMA
JW